Aortic Dissection Clinical Trial
Official title:
18F Sodium Fluoride PET/CT in Acute Aortic Syndrome
The purpose of this study is to determine whether Sodium Fluoride imaging (using Positron Emission Tomography-Computed Tomography - PET-CT) is able to predict disease progression in acute aortic syndrome.
Acute Aortic Syndrome encompasses multiple aortopathies, including aortic dissection, intramural haematoma and penetrating aortic ulcers. Acute aortic syndrome has a three year mortality approaching 25%. To date, other than the initial aortic diameter, there are no accurate methods of establishing the risk of disease progression in patients with acute aortic syndrome. In vascular disease, microcalcification occurs in response to necrotic inflammation. Using computed tomography and positron emission tomography (PET-CT), early microcalcification can be identified using uptake of the radiotracer 18F-sodium fluoride. This can identify high risk-lesions in the aorta, coronary and carotid arteries, and appears to be indicative of necrotic and heavily inflamed tissue. In abdominal aortic aneurysms, 18F-sodium fluoride binding predicts aortic expansion and the risk of aneurysm rupture or requirement for surgical repair. The study investigators, therefore, propose to evaluate the ability of 18F-sodium fluoride to identify regions of necrotic inflammation in acute aortic syndrome to predict aortic expansion and disease progression. Control patients with a normal calibre aorta will be recruited from the National Abdominal Aortic Aneurysm Screening Programme and Vascular Out-Patient Clinics. Patients with acute aortic syndrome and chronic aortic disease will undergo clinical assessments and 18F Sodium Fluoride PET/CT scans at baseline and 12-months. Clinical follow-up will continue for up to 3 years from recruitment. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05582967 -
The DAShED (Diagnosis of Aortic Syndrome in the ED) Study
|
||
Terminated |
NCT04116684 -
Digital Home Blood Pressure Monitoring in Type B Aortic Dissection Patients
|
N/A | |
Completed |
NCT02086136 -
Aortic Dissection Detection Risk Score Plus D-dimer in Suspected Acute Aortic Dissection
|
||
Recruiting |
NCT02201589 -
Feasibility of Endovascular Repair Of Ascending Aortic Pathologies
|
N/A | |
Recruiting |
NCT03948555 -
Magnetic Resonance Imaging (MRI) for Aortic Dissection to Visualise Inflammation
|
||
Enrolling by invitation |
NCT05912608 -
Optimal Strategy for Repair of Type A Acute Aortic Dissection
|
||
Recruiting |
NCT03707743 -
Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique (STABILISE)
|
||
Enrolling by invitation |
NCT00583817 -
Endovascular Treatment of Thoracic Aortic Disease
|
N/A | |
Recruiting |
NCT05073991 -
Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
|
||
Not yet recruiting |
NCT02523300 -
Glucocorticoid on the Prognosis of TEVAR
|
N/A | |
Completed |
NCT01197651 -
Aortic-Stent-Register
|
N/A | |
Recruiting |
NCT04471909 -
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
|
N/A | |
Not yet recruiting |
NCT06044259 -
Study Comparing Hemiarch Replacement and Hemiarch Plus Stent Implantation in Acute Aortic Dissection
|
N/A | |
Completed |
NCT05039814 -
Prediction of Postoperative Acute Kidney Injury in Patients With Acute Type A Aortic Dissection Using Cystatin C
|
||
Recruiting |
NCT03780738 -
A Validation Study of The Relationship Between ALDH2 and Aortic Dissection
|
||
Enrolling by invitation |
NCT05800743 -
Evaluation of the GORE® Ascending Stent Graft
|
N/A | |
Recruiting |
NCT03347812 -
Clinical Study for Evaluating the Safety and Efficacy of Total Endovascular Aortic Arch Repair
|
N/A | |
Completed |
NCT05044494 -
Surgery for Delay-recognized or Defer-operated Type A Aortic Dissection
|
||
Terminated |
NCT02958098 -
My Research Legacy Pilot Study
|
||
Recruiting |
NCT04450433 -
Functional Study of Metabolites in Patients With Aortic Dissection
|